Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Advalight Welcomes Amogh Kothare As New Chief Scientific Officer is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Advalight Welcomes Amogh Kothare As New Chief Scientific Officer - Yahoo Finance

Advalight, the globally renowned company behind ADVATx, the sophisticated dual 589nm and 1319nm wavelength solid-state laser, announces the appointment of Amogh Kothare as Chief Scientific Officer. Read More
Accelerated Cure Project Welcomes New Chief Scientific Officer

Stephanie Buxhoeveden Will Lead iConquerMS™ People-Powered Research Network and Other Research ... Read More
Revibe Technologies Promotes Chief Technical Officer, Welcomes Chief Scientific Officer and Financial Controller as Company Develops ADHD Digital Therapeutic - Markets Insider

WAKE FOREST, N.C., April 28, 2021 /PRNewswire/ -- Revibe Technologies today announced the hiring of Dr. Lindsay Ayearst as Chief Scientific Officer, a new position created to facilitate the ... Read More
GenBio AI Welcomes Emma Lundberg as Co-Founder and Chief Scientific Advisor - Morningstar

"Her passion for science, collaborative spirit, entrepreneurial mindset, and bold ideas make her an incredible addition to our founding team," said Le Song, Chief Technology Officer, GenBio AI. Read More
Fractyl Health Welcomes Dr. Timothy Kieffer as Chief Scientific Officer

Corporate Contact Lisa Davidson, Chief Financial Officer Lisa@fractyl.com, 781.902.8800 Media Contact Beth Brett, Corporate Communications Bbrett@fractyl.com , 720.656.6544 Site Navigation ... Read More
VeriSIM Life Appoints Dr. Szczepan Baran as New Chief Scientific Officer - Business Wire

As Chief Scientific Officer, Szczepan Baran will lead the research and partnership development strategy to promote the efficiency, profitability and competitive position of VeriSIM Life ... Read More
Cure Rare Disease Welcomes New Scientific and Strategic Leaders to Advance Therapies for Ultra-Rare Conditions | News - bakersfield.com

Cure Rare Disease (CRD), a clinical-stage nonprofit biotechnology organization developing genetic therapies for ultra-rare conditions, is proud to announce the appointment of Keith Sutton, PhD, as ... Read More
Engine Biosciences Appoints Renowned Drug Discovery and Development Leader Robert Abraham, PhD, as Chief Scientific Officer - Morningstar

Engine Biosciences Appoints Renowned Drug Discovery and Development Leader Robert Abraham, PhD, as Chief Scientific Officer Provided by PR Newswire Apr 30, 2025, 12:00:00 PM ... Read More
Advalight Welcomes Amogh Kothare As New Chief Scientific Officer

LOS ANGELES, Nov. 20, 2023 /PRNewswire/ -- Advalight, the globally renowned company behind ADVATx, the sophisticated dual 589nm and 1319nm wavelength solid-state laser, announces the appointment ... Read More
Advalight Welcomes Amogh Kothare As New Chief Scientific Officer - OzarksFirst.com

LOS ANGELES, Nov. 20, 2023 /PRNewswire/ -- Advalight, the globally renowned company behind ADVATx, the sophisticated dual 589nm and 1319nm wavelength solid-state laser, announces the appointment ... Read More
Advalight Welcomes Amogh Kothare As New Chief Scientific Officer - KRQE NEWS 13

LOS ANGELES, Nov. 20, 2023 /PRNewswire/ -- Advalight, the globally renowned company behind ADVATx, the sophisticated dual 589nm and 1319nm wavelength solid-state laser, announces the appointment ... Read More
Advalight Welcomes Amogh Kothare As New Chief Scientific Officer - KRON4

LOS ANGELES, Nov. 20, 2023 /PRNewswire/ -- Advalight, the globally renowned company behind ADVATx, the sophisticated dual 589nm and 1319nm wavelength solid-state laser, announces the appointment ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus